# A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee

> **NCT04044742** · PHASE3 · WITHDRAWN · sponsor: **Sorrento Therapeutics, Inc.**

## Conditions studied

- Osteoarthritis, Knee
- Knee Pain Chronic

## Interventions

- **DRUG:** Resiniferatoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04044742
- **Lead sponsor:** Sorrento Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** To be replaced by a different protocol
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044742, "A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04044742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*